These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33112006)

  • 1. Bergenin inhibits bladder cancer progression via activating the PPARγ/PTEN/Akt signal pathway.
    Liu J; Zhang Y; Yu C; Zhang P; Gu S; Wang G; Xiao H; Li S
    Drug Dev Res; 2021 Apr; 82(2):278-286. PubMed ID: 33112006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxysafflor yellow A inhibits the proliferation, migration, and invasion of colorectal cancer cells through the PPARγ/PTEN/Akt signaling pathway.
    Su D; Lv C
    Bioengineered; 2021 Dec; 12(2):11533-11543. PubMed ID: 34889713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Di-(2-ethylhexyl)-phthalate induces apoptosis via the PPARγ/PTEN/AKT pathway in differentiated human embryonic stem cells.
    Fang H; Fang W; Cao H; Luo S; Cong J; Liu S; Pan F; Jia X
    Food Chem Toxicol; 2019 Sep; 131():110552. PubMed ID: 31163220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of isorhamnetin on carbonic anhydrase IX expression and tumorigenesis of bladder cancer by activating PPARγ/PTEN/AKT pathway.
    Zhang P; Sun Y; Shi L; Sun D; Wang L; Feng D; Ding C
    Tissue Cell; 2023 Jun; 82():102048. PubMed ID: 36905861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Jarid2 enhances the progression of bladder cancer through regulating PTEN/AKT signaling.
    Wang X; Lyu J; Ji A; Zhang Q; Liao G
    Life Sci; 2019 Aug; 230():162-168. PubMed ID: 31125562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piceatannol inhibits proliferation and induces apoptosis of bladder cancer cells through regulation of the PTEN/AKT signal pathway.
    Li XG; Zhang WS; Yan XP
    Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):181-184. PubMed ID: 32538768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Specificity Protein 1 (SP1) in Bladder Cancer Progression through PTEN-Mediated AKT/mTOR Pathway.
    Chen Z
    Urol Int; 2023; 107(9):848-856. PubMed ID: 37666229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PPARγ activation serves as therapeutic strategy against bladder cancer via inhibiting PI3K-Akt signaling pathway.
    Lv S; Wang W; Wang H; Zhu Y; Lei C
    BMC Cancer; 2019 Mar; 19(1):204. PubMed ID: 30845932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of Peroxisome Proliferator-Activated Receptor-Gamma (PPARγ) using Pioglitazone Decreases the Survival of Acute Promyelocytic Leukemia Cells through Up-Regulation of PTEN Expression.
    Esmaeili S; Safaroghli-Azar A; Pourbagheri-Sigaroodi A; Salari S; Gharehbaghian A; Hamidpour M; Bashash D
    Anticancer Agents Med Chem; 2021; 21(1):108-119. PubMed ID: 32807067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosiglitazone suppresses human lung carcinoma cell growth through PPARgamma-dependent and PPARgamma-independent signal pathways.
    Han S; Roman J
    Mol Cancer Ther; 2006 Feb; 5(2):430-7. PubMed ID: 16505118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simvastatin induces cell cycle arrest and inhibits proliferation of bladder cancer cells via PPARγ signalling pathway.
    Wang G; Cao R; Wang Y; Qian G; Dan HC; Jiang W; Ju L; Wu M; Xiao Y; Wang X
    Sci Rep; 2016 Oct; 6():35783. PubMed ID: 27779188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circular RNA hsa_circ_0072309 inhibits the proliferation, invasion and migration of gastric cancer cells via inhibition of PI3K/AKT signaling by activating PPARγ/PTEN signaling.
    Guo X; Qin M; Hong H; Xue X; Fang J; Jiang L; Kuang Y; Gao L
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPARγ agonist efatutazone and gefitinib synergistically inhibit the proliferation of EGFR-TKI-resistant lung adenocarcinoma cells via the PPARγ/PTEN/Akt pathway.
    Ni J; Zhou LL; Ding L; Zhao X; Cao H; Fan F; Li H; Lou R; Du Y; Dong S; Liu S; Wang Z; Ma R; Wu J; Feng J
    Exp Cell Res; 2017 Dec; 361(2):246-256. PubMed ID: 29080795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bexarotene inhibits the viability of non-small cell lung cancer cells via slc10a2/PPARγ/PTEN/mTOR signaling pathway.
    Ai X; Mao F; Shen S; Shentu Y; Wang J; Lu S
    BMC Cancer; 2018 Apr; 18(1):407. PubMed ID: 29642873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kaempferol promotes apoptosis in human bladder cancer cells by inducing the tumor suppressor, PTEN.
    Xie F; Su M; Qiu W; Zhang M; Guo Z; Su B; Liu J; Li X; Zhou L
    Int J Mol Sci; 2013 Oct; 14(11):21215-26. PubMed ID: 24284390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glaucocalyxin A induces G2/M cell cycle arrest and apoptosis through the PI3K/Akt pathway in human bladder cancer cells.
    Lin W; Xie J; Xu N; Huang L; Xu A; Li H; Li C; Gao Y; Watanabe M; Liu C; Huang P
    Int J Biol Sci; 2018; 14(4):418-426. PubMed ID: 29725263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosmarinic acid exerts an anticancer effect on osteosarcoma cells by inhibiting DJ-1 via regulation of the PTEN-PI3K-Akt signaling pathway.
    Ma Z; Yang J; Yang Y; Wang X; Chen G; Shi A; Lu Y; Jia S; Kang X; Lu L
    Phytomedicine; 2020 Mar; 68():153186. PubMed ID: 32088353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPARgamma agonists sensitize PTEN-deficient resistant lung cancer cells to EGFR tyrosine kinase inhibitors by inducing autophagy.
    To KKW; Wu WKK; Loong HHF
    Eur J Pharmacol; 2018 Mar; 823():19-26. PubMed ID: 29378193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of microRNA‑21 expression inhibits proliferation, and induces G1 arrest and apoptosis via the PTEN/AKT pathway in SKM‑1 cells.
    Li G; Song Y; Li G; Ren J; Xie J; Zhang Y; Gao F; Mu J; Dai J
    Mol Med Rep; 2018 Sep; 18(3):2771-2779. PubMed ID: 30015844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPARγ inhibition regulates the cell cycle, proliferation and motility of bladder cancer cells.
    Cheng S; Qian K; Wang Y; Wang G; Liu X; Xiao Y; Wang X
    J Cell Mol Med; 2019 May; 23(5):3724-3736. PubMed ID: 30912275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.